Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation
- 21 June 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 38 (1), 53-60
- https://doi.org/10.1038/sj.bmt.1705408
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparison of Quantitative and Qualitative PCR Assays for Cytomegalovirus DNA in PlasmaJournal of Clinical Microbiology, 2001
- Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infectionBone Marrow Transplantation, 2000
- RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1Transplantation, 1998
- Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantationPublished by American Society of Hematology ,1995
- Strategies for the Prevention of Cytomegalovirus Disease After Marrow TransplantationClinical Infectious Diseases, 1994
- Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisBlood, 1994
- Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow TransplantAnnals of Internal Medicine, 1993
- Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction techniqueBlood, 1991
- Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow TransplantsAnnals of Internal Medicine, 1988
- Risk Factors for Cytomegalovirus Infection after Human Marrow TransplantationThe Journal of Infectious Diseases, 1986